These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34731864)

  • 1. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
    Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
    Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
    PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
    Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA).
    Li PK; Dorval M; Johnson DW; Rutherford P; Shutov E; Story K; Bargman JM
    Nephron; 2015; 129(4):233-40. PubMed ID: 25766261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
    Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous glucose monitoring of patients with type 1- and type 2 diabetes on haemodialysis].
    Vadstrup M; Bomholt T; Nørgaard K; Ranjan AG; Rix M; Almdal T; Adrian T; Feldt-Rasmussen B; Hornum M
    Ugeskr Laeger; 2020 Aug; 182(32):. PubMed ID: 32800049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis.
    Zhao C; Luo Q; He F; Peng F; Xia X; Huang F; Yu X
    Diabet Med; 2014 Jul; 31(7):813-20. PubMed ID: 24628621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fructosamine Levels With Glycemic Management in Children With Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results From the CGM TIME Trial.
    Verbeeten KC; Tang K; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML; ;
    Can J Diabetes; 2024 Jul; 48(5):330-336.e2. PubMed ID: 38614216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
    Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis days.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Jørgensen MB; Feldt-Rasmussen B; Hornum M
    Hemodial Int; 2023 Apr; 27(2):126-133. PubMed ID: 36760179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.